General Information of the Compound
Compound ID
CP0373259
Compound Name
N-benzyl-2-[2-[methyl(5-pyrrolidin-1-ylpentyl)amino]-3-phenyl-4H-quinazolin-4-yl]acetamide
    Show/Hide
Synonyms
BDBM50005356
BDBM50197241
CHEMBL393304
KYS-05077
    Show/Hide
Structure
Formula
C33H41N5O
Molecular Weight
523.725
Canonical SMILES
CN(CCCCCN1CCCC1)C1=Nc2ccccc2C(CC(=O)NCc2ccccc2)N1c1ccccc1
    Show/Hide
InChI
InChI=1S/C33H41N5O/c1-36(21-11-4-12-22-37-23-13-14-24-37)33-35-30-20-10-9-19-29(30)31(38(33)28-17-7-3-8-18-28)25-32(39)34-26-27-15-5-2-6-16-27/h2-3,5-10,15-20,31H,4,11-14,21-26H2,1H3,(H,34,39)
    Show/Hide
InChIKey
DKHAGFIMNLTLHC-UHFFFAOYSA-N
Physicochemical Property
logP
6.1398
Rotatable Bonds
11
Heavy Atom Count
39
Polar Areas
51.18
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
39

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 25112470
SID: 56434669
ChEMBL ID
CHEMBL393304
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03095, Voltage-dependent T-type calcium channel subunit alpha-1G
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  2
1
IC50 = 4197.59 nM
   TI
   LI
   LO
   TS
2
IC50 = 4200 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( KYS-05077 )
Drug Name KYS-05077
Target(s)
Voltage-gated calcium channel alpha Cav3.1 (CACNA1G)
Inhibitor
Voltage-gated calcium channel alpha Cav3.2 (CACNA1H)
Inhibitor